BXC - BLUELINX HOLDING （）

Bluelinx Holdings Inc. - Consensus Indicates Potential 27.0% Upside

https://www.investing.com/news/pro/bluelinx-pt-raised-to-105-at-loop-capital-432SI-3012264

BlueLinx Holdings Inc. (NYSE:NYSE:BXC) Q4 2022 Results Conference Call February 22, 2023 10:00 AM ETCompany ParticipantsAlexandra Lukacs - Manager of Investor RelationsDwight Gibson -…

Pulled from Benzinga Pro data, BlueLinx Hldgs (NYSE: BXC ) posted Q4 earnings of $31.99 million, an increase from Q3 of 46.25%. Sales dropped to $847.77 million, a 20.1% decrease between quarters. BlueLinx Hldgs reached earnings of $59.51 million and sales of $1.06 billion in Q3. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth … Full story available on Benzinga.com

BlueLinx has seen investors clambering into the stock in the past 3 months, with its share price substantially outperforming the S&P 500. Find out why I''m bullish on BXC stock.

https://www.investing.com/news/pro/bluelinx-pt-lowered-to-112-at-craighallum-432SI-2931355

BlueLinx Holdings Inc. (NYSE:NYSE:BXC) Q3 2022 Earnings Conference Call November 2, 2022 10:00 ET Company Participants Ryan Taylor - Vice President of Investor Relations Dwight Gibson -…

BlueLinx is an extremely cheap homebuilder distributor. Click here to find out why BXC has a wide margin of safety.

BlueLinx Earnings, Revenue Beat in Q3

MARIETTA, Ga., Nov. 01, 2022 (GLOBE NEWSWIRE) -- BlueLinx Holdings Inc. (NYSE: BXC) , a leading U.S. wholesale distributor of building products, announced today results for the third quarter 2022.

Bluelinx saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 87 to 96.

Gainers Rail Vision Ltd. (NASDAQ: RVSN ) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. TransMedics Group, Inc. (NASDAQ: TMDX ) jumped 40.3% to close at $30.69 after better than expected Q1 earnings and 2022 guidance. Aclarion, Inc. (NASDAQ: ACON ) jumped 36.6% to settle at $2.35 after declining over 5% on Tuesday. The company had its IPO on April 22. Alaunos Therapeutics, Inc. (NASDAQ: TCRT ) jumped 36% to settle at $0.7547 after jumping around 13% on Tuesday. Bright Health Group, Inc. (NYSE: BHG ) gained 33.3% to close at $2.24 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI ) climbed 31.2% to settle at $30.69 after the company reported better-than-expected Q3 EPS and sales results and raised Q4 guidance. Livent Corporation (NYSE: LTHM ) gained 30.3% to close at $28.55 after the company reported better-than-expected Q1 results and raised FY22 guidance. AIkido Pharma Inc. (NASDAQ: AIKI ) jumped 30.1% to settle at $0.4622.

BlueLinx Holdings Inc. (NYSE:NYSE:BXC) Q1 2022 Earnings Conference Call May 4, 2022 10:00 AM ET Company Participants Ryan Taylor – Vice President-Investor Relations Dwight Gibson –…

BlueLinx (BXC) stock is up 22%, Wednesday, after reporting beat on both lines with higher margins in first quarter''s earnings results. Revenue of $1.3B (+26.2% Y/Y) beats by…

BlueLinx reports Q1 2022 results that were meaningfully better than even the most bullish investors could have hoped for. BXC is still priced at approximately 3x earnings.